Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites

Detalhes bibliográficos
Autor(a) principal: Peixoto, Juliana Figueiredo
Data de Publicação: 2023
Outros Autores: Oliveira, Adriane da Silva, Oliveira, Luiz Filipe Gonçalves, Silva, Franklin Souza, Alves, Carlos Roberto
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/58871
Resumo: Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas. Rio de Janeiro, RJ, Brasil.
id CRUZ_355fc849c5b9b94165f84b35419fcd11
oai_identifier_str oai:www.arca.fiocruz.br:icict/58871
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Peixoto, Juliana FigueiredoOliveira, Adriane da SilvaOliveira, Luiz Filipe GonçalvesSilva, Franklin SouzaAlves, Carlos Roberto2023-06-01T18:16:26Z2023-06-01T18:16:26Z2023PEIXOTO, Juliana Figueiredo et al. Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites. The Brazilian Journal of Infection Diseases, v. 27, n. 2,: 102743, p. 1 - 9, Jan. 2023.1413-8670https://www.arca.fiocruz.br/handle/icict/5887110.1016/j.bjid.2023.102743engElsevier España, S.L.U.NaftoquinonaTratamentoLeishimanioseDoença de ChagasMaláriaEpóxi-a-lapachonaNaphthoquinoneEpoxy-a-lapachoneTreatmentLeishmaniasisChagas diseaseMalariaEpoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasitesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil / Universidade Iguaçu. Nova Iguaçu, RJ, Brasil.Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas. Rio de Janeiro, RJ, Brasil.Natural products and their derivatives have been sources of search and research for new drugs for the treatment of neglected diseases. Naphthoquinones, a special group of quinones, are products of natural metabolites with a wide spectrum of biological activities and represent a group of interesting molecules for new therapeutic propositions. Among these compounds, lapachol stands out as a molecule from the heartwood of Tabebuia sp. whose structural changes resulted in compounds considered promising, such as epoxy-a-lapachone (ELAP). The biological activity of ELAP has been demonstrated, so far, for parasitic protozoa such as Leishmania spp., Trypanosoma cruzi and Plasmodium spp., species causing diseases needing new drug development and adequate health policy. This work gathers in vitro and in vivo studies on these parasites, as well as the toxicity profile, and the probable mechanisms of action elucidated until then. The potential of ELAP-based technology alternatives for a further drug is discussed here.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZORIGINALJulianaPeixoto_CarlosAalves_etal_IOC_2023.pdfJulianaPeixoto_CarlosAalves_etal_IOC_2023.pdfapplication/pdf596054https://www.arca.fiocruz.br/bitstream/icict/58871/2/JulianaPeixoto_CarlosAalves_etal_IOC_2023.pdf162ed58fae124d227906ee0242d3373aMD52LICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/58871/1/license.txt5a560609d32a3863062d77ff32785d58MD51icict/588712023-09-04 11:03:15.279oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-09-04T14:03:15Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
title Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
spellingShingle Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
Peixoto, Juliana Figueiredo
Naftoquinona
Tratamento
Leishimaniose
Doença de Chagas
Malária
Epóxi-a-lapachona
Naphthoquinone
Epoxy-a-lapachone
Treatment
Leishmaniasis
Chagas disease
Malaria
title_short Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
title_full Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
title_fullStr Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
title_full_unstemmed Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
title_sort Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites
author Peixoto, Juliana Figueiredo
author_facet Peixoto, Juliana Figueiredo
Oliveira, Adriane da Silva
Oliveira, Luiz Filipe Gonçalves
Silva, Franklin Souza
Alves, Carlos Roberto
author_role author
author2 Oliveira, Adriane da Silva
Oliveira, Luiz Filipe Gonçalves
Silva, Franklin Souza
Alves, Carlos Roberto
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Peixoto, Juliana Figueiredo
Oliveira, Adriane da Silva
Oliveira, Luiz Filipe Gonçalves
Silva, Franklin Souza
Alves, Carlos Roberto
dc.subject.other.en_US.fl_str_mv Naftoquinona
Tratamento
Leishimaniose
Doença de Chagas
Malária
Epóxi-a-lapachona
topic Naftoquinona
Tratamento
Leishimaniose
Doença de Chagas
Malária
Epóxi-a-lapachona
Naphthoquinone
Epoxy-a-lapachone
Treatment
Leishmaniasis
Chagas disease
Malaria
dc.subject.en.en_US.fl_str_mv Naphthoquinone
Epoxy-a-lapachone
Treatment
Leishmaniasis
Chagas disease
Malaria
description Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas. Rio de Janeiro, RJ, Brasil.
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-06-01T18:16:26Z
dc.date.available.fl_str_mv 2023-06-01T18:16:26Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv PEIXOTO, Juliana Figueiredo et al. Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites. The Brazilian Journal of Infection Diseases, v. 27, n. 2,: 102743, p. 1 - 9, Jan. 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/58871
dc.identifier.issn.en_US.fl_str_mv 1413-8670
dc.identifier.doi.none.fl_str_mv 10.1016/j.bjid.2023.102743
identifier_str_mv PEIXOTO, Juliana Figueiredo et al. Epoxy-a-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2Hnaphtho[ 2,3-b]pyran-10,20-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites. The Brazilian Journal of Infection Diseases, v. 27, n. 2,: 102743, p. 1 - 9, Jan. 2023.
1413-8670
10.1016/j.bjid.2023.102743
url https://www.arca.fiocruz.br/handle/icict/58871
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Elsevier España, S.L.U.
publisher.none.fl_str_mv Elsevier España, S.L.U.
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/58871/2/JulianaPeixoto_CarlosAalves_etal_IOC_2023.pdf
https://www.arca.fiocruz.br/bitstream/icict/58871/1/license.txt
bitstream.checksum.fl_str_mv 162ed58fae124d227906ee0242d3373a
5a560609d32a3863062d77ff32785d58
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324693378269184